import Navbar from '@/components/Navbar';
import Footer from '@/components/Footer';
import { Link } from 'react-router-dom';
import { SEOHead } from '@/components/seo/SEOHead';
import { BreadcrumbNav } from '@/components/seo/BreadcrumbNav';
import { FAQSection } from '@/components/healthcare-research/FAQSection';
import { buildBreadcrumbSchema } from '@/lib/seo/schemas';
import { ArrowRight } from 'lucide-react';
import { getStandaloneReportConfig } from '@/data/reportConversionConfig';
import {
  ReportConsultationBand,
  ReportContentWithAside,
  ReportEarlyCtaBar,
  ReportMidPageCta,
  ReportReadingProgress,
} from '@/components/report-conversion';

const breadcrumbItems = [
  { name: 'Home', href: '/' },
  { name: 'France Medical Devices Market Report', href: '/france-medical-devices-market-report' },
];

const REPORT_FAQ_ITEMS = [
  {
    question: 'How big is the France medical devices market in 2026?',
    answer: 'The French medical devices market is estimated at EUR 14–16 billion in 2026, making it the third-largest medical device market in the EU after Germany and the UK. France has approximately 3,000 hospitals and clinics, 74,000 pharmacies, and a strong tradition of medical device innovation through companies including Laboratoires Urgo, Vygon, and Coloplast France. The market is segmented between hospital procurement (approximately 60%) and outpatient/community care (40%). Private clinic groups (Elsan, Ramsay Santé, Almaviva Santé) represent a growing procurement channel alongside the public AP-HP (Assistance Publique-Hôpitaux de Paris) and regional CHU (Centre Hospitalier Universitaire) networks.',
  },
  {
    question: 'How does ANSM regulate medical devices in France under EU MDR?',
    answer: 'ANSM (Agence nationale de sécurité du médicament et des produits de santé) is France\'s national competent authority for medical devices under EU MDR 2017/745 and IVDR 2017/746. CE marking via an EU Notified Body is required for Class IIa, IIb, and III devices. ANSM conducts post-market surveillance, manages the French vigilance system (signalement incidents), and contributes to EMA Notified Body oversight. ANSM operates a dedicated medical device registration system (DMDIV for IVDs) and runs ANSM medical device warning communications. For clinical investigations, French ethics committees (CPP, Comités de Protection des Personnes) are required alongside ANSM authorisation.',
  },
  {
    question: 'How does France reimburse medical devices through the LPP?',
    answer: 'Medical devices eligible for Assurance Maladie reimbursement must be listed on the LPP (Liste des Produits et Prestations). The LPP is maintained by the CNAM and managed through HAS assessment. HAS CNEDIMTS (Commission nationale d\'évaluation des dispositifs médicaux et des technologies de santé) evaluates the ASA (added value in medical service rendered) of new devices seeking LPP listing. The ASA level determines the reimbursement tariff. Hospital devices used within DRG-funded procedures are typically financed within the GHS (Groupement Homogène de Séjours) tariff, though the LPPR/LPP lists hospital-specific high-cost implants that receive separate add-on payment.',
  },
  {
    question: 'What is the Forfait Innovation pathway for innovative medical devices in France?',
    answer: 'Forfait Innovation (FI) is France\'s early access pathway for genuinely innovative medical devices that cannot be adequately reimbursed within existing DRG or LPP frameworks. Under FI, innovative devices can receive temporary conditional reimbursement while real-world evidence is collected in French hospitals. The program requires HAS designation as "innovative" and evidence generation commitments from the manufacturer. Forfait Innovation has covered advanced surgical robotics, novel cardiac devices, and precision diagnostics. It is the key market access pathway for novel medtech seeking rapid French hospital access before full LPP listing.',
  },
  {
    question: 'How do GHT hospital groups affect medical device procurement in France?',
    answer: 'GHT (Groupements Hospitaliers de Territoire) are territorial hospital groups introduced by the Loi de Modernisation du Système de Santé (2016), pooling procurement, clinical protocols, and administrative functions across public hospitals in a defined territory. France has approximately 135 GHTs, each coordinating device procurement for their member hospitals. GHT lead purchasing hospitals negotiate framework contracts on behalf of their entire group. This consolidation means that securing a GHT contract provides access to multiple hospital sites simultaneously — making GHT lead hospital tender decisions critical commercial milestones for device manufacturers.',
  },
  {
    question: 'How does BioNixus support French medtech companies entering the GCC and MENA market?',
    answer: 'BioNixus supports French and European medical device manufacturers in entering GCC and MENA markets. Our services include SFDA (Saudi Arabia), MOHAP/DHA/DOH (UAE), HMC (Qatar), and GCC-wide regulatory pathway mapping; hospital procurement intelligence at key GCC accounts; distributor network evaluation; primary research with biomedical engineers and clinical procurement specialists; and comparative France vs. GCC commercial strategy. BioNixus operates from London with in-country field teams across Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, and Egypt.',
  },
];

const REPORT_CONVERSION = getStandaloneReportConfig('/france-medical-devices-market-report');
const FAQ_SECTION_ID = 'france-medical-devices-faq';

const jsonLd = [
  buildBreadcrumbSchema(breadcrumbItems),
  {
    '@context': 'https://schema.org',
    '@type': 'Article',
    headline: 'France Medical Devices Market Report 2026: LPP Reimbursement, ANSM, and Hospital Procurement Intelligence',
    author: { '@type': 'Organization', name: 'BioNixus' },
    publisher: { '@type': 'Organization', name: 'BioNixus', logo: { '@type': 'ImageObject', url: 'https://www.bionixus.com/bionixus-logo.webp' } },
    datePublished: '2026-05-27',
    dateModified: '2026-05-27',
    mainEntityOfPage: 'https://www.bionixus.com/france-medical-devices-market-report',
  },
  {
    '@context': 'https://schema.org',
    '@type': 'FAQPage',
    url: `https://www.bionixus.com/france-medical-devices-market-report#${FAQ_SECTION_ID}`,
    mainEntity: REPORT_FAQ_ITEMS.map((item) => ({ '@type': 'Question', name: item.question, acceptedAnswer: { '@type': 'Answer', text: item.answer } })),
  },
];

const FranceMedicalDevicesMarketReport = () => (
  <div className="min-h-screen bg-background">
    <Navbar />
    <SEOHead
      title="France Medical Devices Market Report 2026 | LPP Reimbursement, ANSM & GHT Procurement | BioNixus"
      description="France medical devices market at EUR 14–16B in 2026. ANSM regulation under EU MDR, LPP reimbursement listing, Forfait Innovation early access, GHT hospital group procurement, and BioNixus GCC expansion intelligence."
      canonical="https://www.bionixus.com/france-medical-devices-market-report"
      jsonLd={jsonLd}
    />
      <ReportReadingProgress progressId="report-rp-france-medical-devices-market-report" />
      <main>
      <div className="section-padding pt-24 pb-4"><div className="container-wide"><BreadcrumbNav items={breadcrumbItems} /></div></div>
      <section className="section-padding pb-10">
        <div className="container-wide max-w-4xl mx-auto">
          <div className="inline-flex items-center gap-2 px-4 py-2 rounded-full bg-primary/10 text-primary text-xs font-medium mb-6">Published by BioNixus · Updated May 2026 · Open access</div>
          <h1 className="text-3xl md:text-5xl font-display font-bold text-foreground mb-6">France Medical Devices Market Report 2026: LPP Listing, ANSM Regulation, and Hospital Procurement Intelligence</h1>
          <p className="text-muted-foreground leading-relaxed">BioNixus delivers France and EU medical device market intelligence — ANSM regulatory tracking, LPP reimbursement strategy, GHT group procurement research, and GCC/MENA market entry intelligence for French and European medtech manufacturers.</p>
            <ReportEarlyCtaBar config={REPORT_CONVERSION} className="mt-8" />
        </div>
      </section>
      <ReportContentWithAside config={REPORT_CONVERSION} containerClassName="container-wide max-w-6xl mx-auto section-padding">
        <section className="section-padding bg-cream-dark" id="executive-summary">
        <div className="container-wide max-w-4xl mx-auto">
          <h2 className="text-2xl md:text-3xl font-display font-semibold text-foreground mb-6">Executive Summary</h2>
          <div className="bg-white rounded-xl border border-border p-6 shadow-sm mb-6">
            <div className="grid sm:grid-cols-3 gap-6 text-center">
              <div><p className="text-3xl font-display font-bold text-primary">~€14.5B</p><p className="text-xs text-muted-foreground mt-1">France medical devices market 2026</p></div>
              <div><p className="text-3xl font-display font-bold text-primary">~€19B</p><p className="text-xs text-muted-foreground mt-1">Forecast 2030</p></div>
              <div><p className="text-3xl font-display font-bold text-primary">6.2%</p><p className="text-xs text-muted-foreground mt-1">CAGR 2026–2030</p></div>
            </div>
          </div>
          <p className="text-muted-foreground leading-relaxed mb-4">France is the EU's third-largest medical devices market and a significant innovation hub for medtech. The LPP reimbursement list, GHT consolidation of hospital procurement, and the Forfait Innovation pathway are the three defining market access levers for new device technologies seeking French hospital and outpatient access.</p>
          <p className="text-muted-foreground leading-relaxed">See also: <Link to="/france-healthcare-market-report" className="text-primary hover:underline font-medium">France Healthcare Market Report</Link> and <Link to="/gcc-medical-devices-market-report" className="text-primary hover:underline font-medium">GCC Medical Devices Market Report</Link>.</p>
        </div>
      </section>
      <FAQSection sectionId={FAQ_SECTION_ID} title="France medical devices market 2026 — ANSM, LPP, Forfait Innovation, GHT procurement FAQ" items={REPORT_FAQ_ITEMS} className="bg-muted/30" />        </ReportContentWithAside>
      <ReportConsultationBand config={REPORT_CONVERSION} />
        </main>
    <Footer />
  </div>
);

export default FranceMedicalDevicesMarketReport;
